Policy | December 12, 2022
Progress under “PM Surakshit Matritva Abhiyan”
Since inception, more than 3.6 crore pregnant women have received comprehensive ANC under this programme across all states and UTs
Since inception, more than 3.6 crore pregnant women have received comprehensive ANC under this programme across all states and UTs
The service includes full fertility care benefits, including egg and embryo freezing options to employees
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
40,000 visitors and representatives of more than 80 countries set to visit the show
The inspection of the facility resulted in issuance of a Form-483 with eight observations each for the Drug Product facility and API facility at the site
Timely screening and accurate detection through precision diagnostics, targeted therapy, risk reducing surgeries, and comprehensive multimodality treatment options have resulted in improving survival rates and quality of life in cancer patients in India
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
Kauliv provides reusable and disposable pen2 device options to cater to the global market demand.
Subscribe To Our Newsletter & Stay Updated
